Skip to main content
OpenTrials

Clinical trial condition

HRpos Breast Neoplasms

Explore clinical trials studying HRpos Breast Neoplasms. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HRpos Breast Neoplasms trial results

Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details
Completed

Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency

NCT02789332

Conditions
BRCA 1 /2 and / or HRD, Breast Cancer, Breast Diseases, +8 more
Locations
  • Kliniken Esslingen, Gynäkologie Onkologie Esslingen am Neckar, Baden-Wurttemberg, Germany
  • Universitätsklinikum Erlangen Erlangen, Bavaria, Germany
  • Onkologisches Zentrum am Rotkreuzklinikum München München, Bavaria, Germany
  • Elisabeth Krankenhaus Kassel, Hesse, Germany
View Trial Details

Related conditions